Stockholders' Equity, Summary (Details)	1 Months Ended		12 Months Ended
	Jun. 30, 2021 USD ($) $ / shares shares	May 31, 2021 USD ($) shares	Dec. 31, 2022 USD ($) shares	Dec. 31, 2021 shares	Jul. 12, 2022 USD ($)	Jan. 31, 2017 $ / shares shares
Stockholders Equity [Abstract]
Number of shares authorized, for all classes of stock (in shares)						169,000,000
Share price (in dollars per share) | $ / shares						$ 0.001
Common stock, issued (in shares)		9	11,986,927	11,921,388
Common stock, outstanding (in shares)		9	11,869,704	11,804,165
Reverse stock split of common stock		0.11
Number of votes per share			one
Deferred offering costs | $	$ 1,591,143	$ 188,544	$ 95
IPO [Member]
Stockholders Equity [Abstract]
Shares issued and sold (in shares)	2,650,000
Share price (in dollars per share) | $ / shares	$ 13
Proceeds from issuance after deducting underwriting discounts, commissions, and legal expenses | $	$ 31,613,500
Deferred offering costs | $	2,016,143
Legal expenses incurred paid by underwriters | $	$ 425,000
Automatic conversion of preferred stock in connection with IPO (in shares)	8,116,343
Common Stock [Member]
Stockholders Equity [Abstract]
Number of shares authorized, for all classes of stock (in shares)			200,000,000			95,853,558
Shares issued and sold (in shares)			51,251	2,650,000
Automatic conversion of preferred stock in connection with IPO (in shares)				8,116,343
Authorized offering amount of securities | $					$ 8,800,000
Preferred Stock [Member]
Stockholders Equity [Abstract]
Number of shares authorized, for all classes of stock (in shares)			10,000,000			73,146,442
Shares issued and sold (in shares)				0
Automatic conversion of preferred stock in connection with IPO (in shares)				(17,210,609)